通策医疗2024年度拟派2.01亿元红包

Company Overview - Tongce Medical announced a 2024 annual distribution plan, proposing a cash dividend of 4.5 yuan per 10 shares (including tax), with a total cash distribution amounting to 201 million yuan, representing 40.14% of the net profit [2] - The company reported a revenue of 2.874 billion yuan for the year, reflecting a year-on-year growth of 0.96%, and a net profit of 501 million yuan, which is a 0.20% increase compared to the previous year [2] Dividend History - This marks the fourth cumulative cash distribution since the company's listing, with the following historical distribution plans: - 2024: 10 shares distributed 4.5 yuan (total cash: 201 million yuan, dividend yield: 0.84%) - 2023: 10 shares distributed 4.3565 yuan (total cash: 139 million yuan, dividend yield: 0.39%) - 2017: 10 shares distributed 0.3 yuan (total cash: 10 million yuan, dividend yield: 0.11%) - 2016: 10 shares distributed 1.3 yuan (total cash: 42 million yuan, dividend yield: 0.40%) [2] Market Performance - The stock experienced a net outflow of 197,400 yuan from main funds today, with a total net outflow of 11.9 million yuan over the past five days [3] - The latest margin financing balance for the stock is 852 million yuan, with an increase of 15.57 million yuan over the past five days, representing a growth of 1.86% [4] Industry Context - In the pharmaceutical and biotechnology sector, 255 companies have announced their 2024 distribution plans, with WuXi AppTec leading with a cash distribution of 7.692 billion yuan, followed by Yunnan Baiyao and Aier Eye Hospital with distributions of 2.114 billion yuan and 1.488 billion yuan, respectively [4]